[A15-22] Dulaglutide (Addendum to Commission A15-07)
Last updated 16.07.2015
Commission awarded on 09.06.2015 by the Federal Joint Committee (G-BA).
Digestion, metabolism and hormones
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
|A15-07||Dulaglutide - Benefit assessment according to §35a Social Code Book V (dossier assessment)||Commission completed|